Follow
Kassidy M Jungles
Kassidy M Jungles
Graduate Student Research Assistant, University of Michigan
Verified email at umich.edu
Title
Cited by
Cited by
Year
The infant microbiome and its impact on development of food allergy
KN Jungles, KM Jungles, L Greenfield, M Mahdavinia
Immunology and Allergy Clinics 41 (2), 285-299, 2021
162021
RB expression confers sensitivity to CDK4/6 inhibitor–mediated radiosensitization across breast cancer subtypes
AM Pesch, NH Hirsh, AR Michmerhuizen, KM Jungles, K Wilder-Romans, ...
JCI insight 7 (3), 2022
112022
Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models
AR Michmerhuizen, LM Lerner, AM Pesch, C Ward, R Schwartz, ...
NPJ Breast Cancer 8 (1), 31, 2022
72022
High-content CRISPR screening in tumor immunology
EA Holcomb, AN Pearson, KM Jungles, A Tate, J James, L Jiang, ...
Frontiers in Immunology 13, 1041451, 2022
62022
Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer
KM Jungles, EA Holcomb, AN Pearson, KR Jungles, CR Bishop, ...
Frontiers in Oncology 12, 1022542, 2022
62022
Bcl-xL Inhibition Radiosensitizes PIK3CA/PTEN Wild-type Triple-negative Breast Cancers with Low Mcl-1 Expression
AM Pesch, BC Chandler, AR Michmerhuizen, HM Carter, NH Hirsh, ...
Cancer research communications 2 (7), 679-693, 2022
42022
Catalase deficiency compromises survival in extracellular matrix-detached SKOV3 ovarian cancer cells
CL Libbing, KM Jungles, E Rabaut, CA Davison-Versagli
React Oxyg Species (Apex) 7 (20), 121-8, 2019
32019
Fat fuels the fire in cervical cancer
KM Jungles, MD Green
Cancer Research 82 (24), 4513-4514, 2022
22022
Transcriptomic Analysis to Uncover the Mechanism of Radiosensitization of AR-Positive Triple Negative Breast Cancers with AR Inhibition
CE Pisano, B McBean, AR Michmerhuizen, B Chandler, A Pesch, C Ward, ...
International Journal of Radiation Oncology, Biology, Physics 117 (2), e255, 2023
12023
Peroxiredoxin 2 controls proliferation in extracellular matrix-detached SKOV3 ovarian cancer cells
KM Jungles, D Bondarenko, M Sanchez, KA Schramm, ...
Reactive Oxygen Species 9 (27), 109–117-109–117, 2020
12020
Targeting aurora kinase B (AURKB) as a radiosensitizing strategy in syngeneic models of triple negative breast cancer (TNBC)
KM Jungles, Z Wang, C Bishop, C Wilson, M Liu, J James, M Green, ...
Cancer Research 84 (6_Supplement), 708-708, 2024
2024
Potentiating the radiation-induced type I interferon anti-tumoral immune response by ATM inhibition in pancreatic cancer
Q Zhang, L Jiang, W Wang, AK Huber, VM Valvo, KM Jungles, ...
JCI insight, 2024
2024
Liver Metastases Potentiate Cancer Progression
AN Pearson, E Holcomb, J James, KM Jungles, N Nedzesky, G Schaefer, ...
The Journal of Immunology 210 (1_Supplement), 88.09-88.09, 2023
2023
The radiosensitizing effects of monopolar spindle kinase I in syngeneic models of triple negative breast cancer and its implications on the tumor immune microenvironment
KM Jungles, Z Wang, C Bishop, KR Jungles, C Wilson, M Liu, AN Pearson, ...
The Journal of Immunology 210 (1_Supplement), 245.06-245.06, 2023
2023
CRISPR-Cas9 screen identifies potential novel regulators of CD8+ T cell dysfunction
EA Holcomb, L Jiang, A Tate, AN Pearson, Z Wang, KM Jungles, J James, ...
The Journal of Immunology 210 (1_Supplement), 86.13-86.13, 2023
2023
Targeting monopolar spindle kinase I (TTK) as a radiosensitizing strategy in syngeneic murine models of triple negative breast cancer (TNBC) and its implications on the tumor …
KM Jungles, Z Wang, CR Bishop, KR Jungles, C Wilson, M Liu, ...
Cancer Research 83 (7_Supplement), 2823-2823, 2023
2023
Conoidin A Abrogates Growth of Anchorage-Dependent and Anchorage-Independent SKOV3 Ovarian Cancer Cells
KM Borger, KM Jungles, M Powell, M Sanchez, CA Davison-Versagli
Reactive Oxygen Species 12, r9–r17-r9–r17, 2022
2022
Inhibition of estrogen receptor signaling as a strategy for radiosensitization of ER+ breast cancers
AR Michmerhuizen, LM Lerner, AM Pesch, C Ward, R Schwartz, ...
Cancer Research 82 (12_Supplement), 2697-2697, 2022
2022
Expression of DNA damage response proteins modifies the efficacy of CDK4/6 inhibitor-mediated radiosensitization in breast cancer models
KM Jungles, AM Pesch, N Hirsh, AR Michmerhuizen, K Wilder-Romans, ...
Cancer Research 82 (12_Supplement), 216-216, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–19